Literature DB >> 19507168

Lessons learned from the clinical reappraisal study of the Composite International Diagnostic Interview with Latinos.

Margarita Alegria1, Patrick E Shrout, Maria Torres, Roberto Lewis-Fernández, Jamie M Abelson, Meris Powell, Alejandro Interian, Julia Lin, Mara Laderman, Glorisa Canino.   

Abstract

Given recent adaptations of the World Health Organization's World Mental Health Composite International Diagnostic Interview (WMH-CIDI), new methodological studies are needed to evaluate the concordance of CIDI diagnoses with clinical diagnostic interviews. This paper summarizes lessons learned from a clinical reappraisal study done with US Latinos. We compare CIDI diagnoses with independent clinical diagnosis using the World Mental Health Structured Clinical Interview for DSM-IV (WMH-SCID 2000). Three sub-samples stratified by diagnostic status (CIDI positive, CIDI negative, or CIDI sub-threshold for a disorder) based on nine disorders were randomly selected for a telephone re-interview using the SCID. We calculated sensitivity, specificity, and weight-adjusted Cohen's kappa. Weighted 12 month prevalence estimates of the SCID are slightly higher than those of the CIDI for generalized anxiety disorder, alcohol abuse/dependence, and drug abuse/dependence. For Latinos, CIDI-SCID concordance at the aggregate disorder level is comparable, albeit lower, to other published reports. The CIDI does very well identifying negative cases and classifying disorders at the aggregate level. Good concordance was also found for major depressive episode and panic disorder. Yet, our data suggests that the CIDI presents problems for assessing post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). Recommendations on how to improve future versions of the CIDI for Latinos are offered. 2009 John Wiley & Sons, LTD

Entities:  

Mesh:

Year:  2009        PMID: 19507168      PMCID: PMC2729144          DOI: 10.1002/mpr.280

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  27 in total

1.  Case ascertainment: the Composite International Diagnostic Interview.

Authors:  G Andrews
Journal:  Aust N Z J Psychiatry       Date:  2000-11       Impact factor: 5.744

2.  A cross-cultural adaptation of a psychiatric epidemiologic instrument: the diagnostic interview schedule's adaptation in Puerto Rico.

Authors:  M Bravo; G J Canino; M Rubio-Stipec; M Woodbury-Fariña
Journal:  Cult Med Psychiatry       Date:  1991-03

3.  Psychotropic drug presentation in medical and lay press journals.

Authors:  C Correll; M Linden
Journal:  Pharmacopsychiatry       Date:  2005-07       Impact factor: 5.788

4.  Comparison of Composite International Diagnostic Interview and clinical DSM-III-R criteria checklist diagnoses.

Authors:  A Janca; L N Robins; K K Bucholz; T S Early; J J Shayka
Journal:  Acta Psychiatr Scand       Date:  1992-06       Impact factor: 6.392

5.  A re-analysis of the reliability of psychiatric diagnosis.

Authors:  R L Spitzer; J L Fleiss
Journal:  Br J Psychiatry       Date:  1974-10       Impact factor: 9.319

6.  Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey.

Authors:  B F Grant
Journal:  J Subst Abuse       Date:  1996

7.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

8.  The National Comorbidity Survey Replication (NCS-R): background and aims.

Authors:  Ronald C Kessler; Kathleen R Merikangas
Journal:  Int J Methods Psychiatr Res       Date:  2004       Impact factor: 4.035

9.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.

Authors:  Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji
Journal:  JAMA       Date:  2004-06-02       Impact factor: 56.272

10.  Trauma in war and political persecution: expanding the concept.

Authors:  Pilar Hernández
Journal:  Am J Orthopsychiatry       Date:  2002-01
View more
  40 in total

1.  Validation of diagnoses of distress disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).

Authors:  Jennifer Greif Green; Shelli Avenevoli; Michael J Gruber; Ronald C Kessler; Matthew D Lakoma; Kathleen Ries Merikangas; Nancy A Sampson; Alan M Zaslavsky
Journal:  Int J Methods Psychiatr Res       Date:  2011-11-15       Impact factor: 4.035

2.  Translating Research into Practice: Employing Community-Based Mixed Methods Approaches to Address Chronic Disease and Depression Among Latinos.

Authors:  Jaime Corvin; Claudia Aguado Loi; Moya Alfonso; Dinorah Martinez Tyson; Isabella Chan; Pinzon Maria; Junius Gonzales
Journal:  J Behav Health Serv Res       Date:  2017-10       Impact factor: 1.505

3.  Age at first drink, drinking, binge drinking, and DSM-5 alcohol use disorder among Hispanic national groups in the United States.

Authors:  Raul Caetano; Britain A Mills; Patrice A C Vaeth; Jennifer Reingle
Journal:  Alcohol Clin Exp Res       Date:  2014-04-01       Impact factor: 3.455

4.  Psychosocial risk factors and asthma among adults in Puerto Rico.

Authors:  Yueh-Ying Han; Erick Forno; Glorisa Canino; Juan C Celedón
Journal:  J Asthma       Date:  2018-06-06       Impact factor: 2.515

5.  DSM-5 Alcohol Use Disorder Severity in Puerto Rico: Prevalence, Criteria Profile, and Correlates.

Authors:  Raul Caetano; Paul Gruenewald; Patrice A C Vaeth; Glorisa Canino
Journal:  Alcohol Clin Exp Res       Date:  2018-01-02       Impact factor: 3.455

6.  Predictors of treatment utilization and unmet treatment need among individuals with posttraumatic stress disorder from a national sample.

Authors:  Carrie J Nobles; Sarah E Valentine; Monica W Gerber; Derri L Shtasel; Luana Marques
Journal:  Gen Hosp Psychiatry       Date:  2016-09-09       Impact factor: 3.238

7.  A comparison of the prevalence of psychiatric disorders in Puerto Rico with the United States and the Puerto Rican population of the United States.

Authors:  Glorisa Canino; Patrick E Shrout; Amanda NeMoyer; Doryliz Vila; Katyana M Santiago; Pedro Garcia; Amarilis Quiñones; Vilmary Cruz; Margarita Alegria
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-01-16       Impact factor: 4.328

8.  Sensitivity and Specificity in Three Measures of Depression Among Mexican American Women.

Authors:  Dellanira Valencia-Garcia; Xiaoyu Bi; Cecilia Ayón
Journal:  J Immigr Minor Health       Date:  2017-06

9.  Transnational ties and past-year major depressive episodes among Latino immigrants.

Authors:  Carmela Alcántara; Chih-Nan Chen; Margarita Alegría
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2014-08-04

Review 10.  Conditional risk for PTSD among Latinos: a systematic review of racial/ethnic differences and sociocultural explanations.

Authors:  Carmela Alcántara; Melynda D Casement; Roberto Lewis-Fernández
Journal:  Clin Psychol Rev       Date:  2012-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.